Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Inhibitory effect of clomipramine and related drugs on serotonin uptake in platelets: More complicated than previously thought

  • 25 Accesses

  • 29 Citations

Abstract

Clomipramine and related tricyclic antidepressants are strong inhibitors of serotonin uptake in platelets and brain tissue. Usually, the inhibition in platelets has been reported to be competitive, but in some recent reports it is claimed to be noncompetitive. In this study on the effect of clomipramine, imipramine and some related drugs on serotonin uptake in human blood platelets in a protein-free medium, stress is laid on the use of an adequate blind value and correction for rapid decrease in substrate concentration during the incubation.

Pure competitive inhibition was found for imipramine and desmethylchlomipramine, with increased Michaelis' constant (K m) without change in maximal uptake rate (V max). Clomipramine, however, and to a lesser degree the new compound citalopram (Lu 10-171), also reduces V max) indicating a mixed competitive and noncompetitive inhibitory effect event at extremely low concentrations (in the order of 10-9–10-8 M). The noncompetitive component of the clomipramine inhibition is not significantly influenced by increasing the period of preincubation, by varying pH, or by increasing the concentration of potassium. Contrary to desmethylclomipramine, however, clomipramine seems to interfere with the effect of chloride in the uptake process, by blocking the otherwise stimulatory effect of higher concentrations of this anion.

This is a preview of subscription content, log in to check access.

References

  1. Åsberg, M., Thorén, P., Träskman, L., Bertilsson, L., Ringberger, V.: “Serotonin depression” — a biochemical subgroup within the affective disorders? Science 191, 478–480 (1976)

  2. Carlsson, A., Fuxe, K., Ungerstedt, U.: The effect of imipramine on central 5-hydroxytryptamine neurons. J. Pharm. Pharmacol. 20, 150–151 (1968)

  3. Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-ethyl-metatyramine. Eur. J. Pharmacol. 5, 357–366 (1969)

  4. Lapin, I. P., Oxenkrug, G. F.: Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969 I, 132–136

  5. Le Fur, G., Uzan, A.: Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in the rat brain synaptosomes, rat heart and human blood platelets. Biochem. Pharmacol. 26, 497–503 (1977)

  6. Lingjærde, O.: Uptake of serotonin in blood platelets in vitro. I. The effects of chloride. Acta Physiol. Scand. 81, 75–83 (1971)

  7. Lingjærde, O.: Effect of doxepin on uptake and efflux of serotonin in human blood platelets in vitro. Psychopharmacology 47, 183–186 (1976)

  8. Lingjærde, O.: Platelet uptake and storage of serotonin. In: Serotonin in health and disease, vol. 4, W. B. Essman, ed., pp. 139–199. New York: Spectrum 1977a

  9. Lingjærde, O.: Virkningen av tricykliske antidepressiva på serotonin-opptak i humane blodplater, in vitro og in vivo. Nord. Psykiatr. Tskr. 31, 384–393 (1977b)

  10. Long, R. F., Lessin, A. W.: Inhibition of 5-hydroxytryptamine uptake by platelets in vitro and in vivo. Biochem. J 82, 5P (1962)

  11. Marshall, E. F., Stirling, G. S., Tait, A. C., Todrick, A.: the effect of iproniazide and imipramine on the blood platelet 5-hydroxytryptamine level in man. Br. J. Pharmacol. 15, 35–41 (1960)

  12. Sneddon, J. M.: Blood platelets as a model for monoamine-containing neurones. In: Progress in neurobiology, vol I, part 2, G. A. Kerkut and J. W. Phillis, eds., pp. 153–198. New York: Pergamon 1973

  13. Stacey, R. D.: Uptake of 5-hydroxytryptamine by platelets. Br. J. Pharmacol. 16, 284–295 (1961)

  14. Todrick, A., Tait, C.: The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs. The relation between structure and potency. J. Pharm. Pharmacol. 21, 751–762 (1969)

  15. Trenchard, A., Turner, P., Pare, C. M. B., Hills, M.: The effects of protriptyline and clomipramine in vitro on the uptake of 5-hydroxytryptamine and dopamine in human platelet-rich plasma. Psychopharmacologia (Berl.) 43, 89–93 (1975)

  16. Tuomisto, J.: A new modification for studying 5-HT uptake by blood platelets: a re-evaluation of tricyclic antidepressants as uptake inhibitors. J. Pharm. Pharmacol. 26, 92–100 (1974)

  17. Wielosz, M., Salmona, M., Gaetano, G. de, Garattini S.: Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. Naunyn Schmiedebergs Arch. Pharmacol. 296, 59–65 (1976)

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lingjærde, O. Inhibitory effect of clomipramine and related drugs on serotonin uptake in platelets: More complicated than previously thought. Psychopharmacology 61, 245–249 (1979). https://doi.org/10.1007/BF00432266

Download citation

Key words

  • Clomipramine
  • Tricyclic antidepressants
  • Inhibition kinetics
  • Serotonin uptake
  • Blood platelets